• امروز : شنبه, ۱ دی , ۱۴۰۳
  • برابر با : Saturday - 21 December - 2024
امروز 0

Research and Development

۱۴خرداد
American Association for Cancer Research, April 5-10
Cancer

American Association for Cancer Research, April 5-10

The investigators evaluated the safety and efficacy of saruparib among 306 patients with previously treated HRR-deficient breast, ovarian, pancreatic, or prostate cancer.